Quote | Oncorus Inc. (NASDAQ:ONCR)
Last: | $0.12055 |
---|---|
Change Percent: | -3.34% |
Open: | $0.1362 |
Close: | $0.12055 |
High: | $0.15 |
Low: | $0.1121 |
Volume: | 8,755,174 |
Last Trade Date Time: | 06/20/2023 03:00:00 am |
News | Oncorus Inc. (NASDAQ:ONCR)
iClick Interactive Asia Group Limited (ICLK) is expected to report for quarter end 2023-09-30 Applied Minerals Inc (AMNL) is expected to report for quarter end 2023-09-30 Banco Do Brasil S.A. ADR (BDORY) is expected to report for Q3 2023 Rubius Therapeutics Inc. (RUBY) is expected to ...
American Bio Medica Corp. (ABMC) is expected to report for quarter end 2023-09-30 Surgalign Holdings Inc. (SRGAQ) is expected to report for quarter end 2023-09-30 MillerKnoll Inc. (MLKN) is expected to report $0.52 for Q2 2024 Ping AN Insurance (Group) Co. of China, Ltd. ADR - Level I...
Message Board Posts | Oncorus Inc. (NASDAQ:ONCR)
Subject | By | Source | When |
---|---|---|---|
288k shares sold, took $ONCR down 18%..... guess | reena969 | investorshub | 01/19/2023 6:16:18 PM |
added more ............ $81 million in cash and | reena969 | investorshub | 01/17/2023 10:10:32 PM |
AH volume...added .44 | reena969 | investorshub | 01/17/2023 9:16:16 PM |
Agree | Golden Cross | investorshub | 06/10/2022 12:57:01 AM |
Low float, could run big. | lvhd | investorshub | 06/09/2022 4:20:14 PM |
News, Short Squeeze, Breakout and More Instantly...
iClick Interactive Asia Group Limited (ICLK) is expected to report for quarter end 2023-09-30 Applied Minerals Inc (AMNL) is expected to report for quarter end 2023-09-30 Banco Do Brasil S.A. ADR (BDORY) is expected to report for Q3 2023 Rubius Therapeutics Inc. (RUBY) is expected to ...
American Bio Medica Corp. (ABMC) is expected to report for quarter end 2023-09-30 Surgalign Holdings Inc. (SRGAQ) is expected to report for quarter end 2023-09-30 MillerKnoll Inc. (MLKN) is expected to report $0.52 for Q2 2024 Ping AN Insurance (Group) Co. of China, Ltd. ADR - Level I...
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...